Global Biosimilars and Innovative Biological Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global Biosimilars and Innovative Biological Drugs market size is projected to grow from US$ 424560 million in 2024 to US$ 713020 million in 2030; it is expected to grow at a CAGR of 9.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Biosimilars and Innovative Biological Drugs Industry Forecast” looks at past sales and reviews total world Biosimilars and Innovative Biological Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Biosimilars and Innovative Biological Drugs sales for 2023 through 2029. With Biosimilars and Innovative Biological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilars and Innovative Biological Drugs industry.
This Insight Report provides a comprehensive analysis of the global Biosimilars and Innovative Biological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biosimilars and Innovative Biological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biosimilars and Innovative Biological Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilars and Innovative Biological Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilars and Innovative Biological Drugs.
United States market for Biosimilars and Innovative Biological Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Biosimilars and Innovative Biological Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Biosimilars and Innovative Biological Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Biosimilars and Innovative Biological Drugs players cover Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars and Innovative Biological Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global Biosimilars and Innovative Biological Drugs market size is projected to grow from US$ 424560 million in 2024 to US$ 713020 million in 2030; it is expected to grow at a CAGR of 9.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Biosimilars and Innovative Biological Drugs Industry Forecast” looks at past sales and reviews total world Biosimilars and Innovative Biological Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Biosimilars and Innovative Biological Drugs sales for 2023 through 2029. With Biosimilars and Innovative Biological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilars and Innovative Biological Drugs industry.
This Insight Report provides a comprehensive analysis of the global Biosimilars and Innovative Biological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biosimilars and Innovative Biological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biosimilars and Innovative Biological Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilars and Innovative Biological Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilars and Innovative Biological Drugs.
United States market for Biosimilars and Innovative Biological Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Biosimilars and Innovative Biological Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Biosimilars and Innovative Biological Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Biosimilars and Innovative Biological Drugs players cover Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars and Innovative Biological Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies
- Interferon
- Insulin
- Vaccines
- Others
- Hospital
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Monoclonal Antibodies
- Interferon
- Insulin
- Vaccines
- Others
- Hospital
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- Biogen
- Celltrion
- Sobi
- 3SBIO
- Changchun High Tech
- Kanghong Pharma
- Innovent Biologics
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars and Innovative Biological Drugs Market Size 2019-2030
2.1.2 Biosimilars and Innovative Biological Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biosimilars and Innovative Biological Drugs by Country/Region, 2019, 2023 & 2030
2.2 Biosimilars and Innovative Biological Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Insulin
2.2.4 Vaccines
2.2.5 Others
2.3 Biosimilars and Innovative Biological Drugs Market Size by Type
2.3.1 Biosimilars and Innovative Biological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
2.4 Biosimilars and Innovative Biological Drugs Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Biosimilars and Innovative Biological Drugs Market Size by Application
2.5.1 Biosimilars and Innovative Biological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
3 BIOSIMILARS AND INNOVATIVE BIOLOGICAL DRUGS MARKET SIZE BY PLAYER
3.1 Biosimilars and Innovative Biological Drugs Market Size Market Share by Player
3.1.1 Global Biosimilars and Innovative Biological Drugs Revenue by Player (2019-2024)
3.1.2 Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Biosimilars and Innovative Biological Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOSIMILARS AND INNOVATIVE BIOLOGICAL DRUGS BY REGION
4.1 Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024)
4.2 Global Biosimilars and Innovative Biological Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
4.4 APAC Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
4.5 Europe Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024)
5.2 Americas Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
5.3 Americas Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024)
6.2 APAC Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
6.3 APAC Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024)
7.2 Europe Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
7.3 Europe Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars and Innovative Biological Drugs by Region (2019-2024)
8.2 Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOSIMILARS AND INNOVATIVE BIOLOGICAL DRUGS MARKET FORECAST
10.1 Global Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.1.1 Global Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.1.2 Americas Biosimilars and Innovative Biological Drugs Forecast
10.1.3 APAC Biosimilars and Innovative Biological Drugs Forecast
10.1.4 Europe Biosimilars and Innovative Biological Drugs Forecast
10.1.5 Middle East & Africa Biosimilars and Innovative Biological Drugs Forecast
10.2 Americas Biosimilars and Innovative Biological Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Biosimilars and Innovative Biological Drugs Forecast
10.2.2 Canada Market Biosimilars and Innovative Biological Drugs Forecast
10.2.3 Mexico Market Biosimilars and Innovative Biological Drugs Forecast
10.2.4 Brazil Market Biosimilars and Innovative Biological Drugs Forecast
10.3 APAC Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.3.1 China Biosimilars and Innovative Biological Drugs Market Forecast
10.3.2 Japan Market Biosimilars and Innovative Biological Drugs Forecast
10.3.3 Korea Market Biosimilars and Innovative Biological Drugs Forecast
10.3.4 Southeast Asia Market Biosimilars and Innovative Biological Drugs Forecast
10.3.5 India Market Biosimilars and Innovative Biological Drugs Forecast
10.3.6 Australia Market Biosimilars and Innovative Biological Drugs Forecast
10.4 Europe Biosimilars and Innovative Biological Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Biosimilars and Innovative Biological Drugs Forecast
10.4.2 France Market Biosimilars and Innovative Biological Drugs Forecast
10.4.3 UK Market Biosimilars and Innovative Biological Drugs Forecast
10.4.4 Italy Market Biosimilars and Innovative Biological Drugs Forecast
10.4.5 Russia Market Biosimilars and Innovative Biological Drugs Forecast
10.5 Middle East & Africa Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Biosimilars and Innovative Biological Drugs Forecast
10.5.2 South Africa Market Biosimilars and Innovative Biological Drugs Forecast
10.5.3 Israel Market Biosimilars and Innovative Biological Drugs Forecast
10.5.4 Turkey Market Biosimilars and Innovative Biological Drugs Forecast
10.6 Global Biosimilars and Innovative Biological Drugs Forecast by Type (2025-2030)
10.7 Global Biosimilars and Innovative Biological Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biosimilars and Innovative Biological Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Biosimilars and Innovative Biological Drugs Product Offered
11.1.3 Roche Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Biosimilars and Innovative Biological Drugs Product Offered
11.2.3 Amgen Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Biosimilars and Innovative Biological Drugs Product Offered
11.3.3 AbbVie Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Biosimilars and Innovative Biological Drugs Product Offered
11.4.3 Sanofi Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Biosimilars and Innovative Biological Drugs Product Offered
11.5.3 Johnson & Johnson Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Biosimilars and Innovative Biological Drugs Product Offered
11.6.3 Pfizer Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Biosimilars and Innovative Biological Drugs Product Offered
11.7.3 Novo Nordisk Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novo Nordisk Main Business Overview
11.7.5 Novo Nordisk Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Biosimilars and Innovative Biological Drugs Product Offered
11.8.3 Eli Lilly Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Biosimilars and Innovative Biological Drugs Product Offered
11.9.3 Novartis Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Biosimilars and Innovative Biological Drugs Product Offered
11.10.3 Merck Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Biogen
11.11.1 Biogen Company Information
11.11.2 Biogen Biosimilars and Innovative Biological Drugs Product Offered
11.11.3 Biogen Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biogen Main Business Overview
11.11.5 Biogen Latest Developments
11.12 Celltrion
11.12.1 Celltrion Company Information
11.12.2 Celltrion Biosimilars and Innovative Biological Drugs Product Offered
11.12.3 Celltrion Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Celltrion Main Business Overview
11.12.5 Celltrion Latest Developments
11.13 Sobi
11.13.1 Sobi Company Information
11.13.2 Sobi Biosimilars and Innovative Biological Drugs Product Offered
11.13.3 Sobi Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Sobi Main Business Overview
11.13.5 Sobi Latest Developments
11.14 3SBIO
11.14.1 3SBIO Company Information
11.14.2 3SBIO Biosimilars and Innovative Biological Drugs Product Offered
11.14.3 3SBIO Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 3SBIO Main Business Overview
11.14.5 3SBIO Latest Developments
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Information
11.15.2 Changchun High Tech Biosimilars and Innovative Biological Drugs Product Offered
11.15.3 Changchun High Tech Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Changchun High Tech Main Business Overview
11.15.5 Changchun High Tech Latest Developments
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Information
11.16.2 Kanghong Pharma Biosimilars and Innovative Biological Drugs Product Offered
11.16.3 Kanghong Pharma Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Kanghong Pharma Main Business Overview
11.16.5 Kanghong Pharma Latest Developments
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Information
11.17.2 Innovent Biologics Biosimilars and Innovative Biological Drugs Product Offered
11.17.3 Innovent Biologics Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Innovent Biologics Main Business Overview
11.17.5 Innovent Biologics Latest Developments
11.18 Gan&Lee
11.18.1 Gan&Lee Company Information
11.18.2 Gan&Lee Biosimilars and Innovative Biological Drugs Product Offered
11.18.3 Gan&Lee Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Gan&Lee Main Business Overview
11.18.5 Gan&Lee Latest Developments
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Information
11.19.2 Tonghua Dongbao Biosimilars and Innovative Biological Drugs Product Offered
11.19.3 Tonghua Dongbao Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Tonghua Dongbao Main Business Overview
11.19.5 Tonghua Dongbao Latest Developments
11.20 United Laboratory
11.20.1 United Laboratory Company Information
11.20.2 United Laboratory Biosimilars and Innovative Biological Drugs Product Offered
11.20.3 United Laboratory Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 United Laboratory Main Business Overview
11.20.5 United Laboratory Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars and Innovative Biological Drugs Market Size 2019-2030
2.1.2 Biosimilars and Innovative Biological Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biosimilars and Innovative Biological Drugs by Country/Region, 2019, 2023 & 2030
2.2 Biosimilars and Innovative Biological Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Insulin
2.2.4 Vaccines
2.2.5 Others
2.3 Biosimilars and Innovative Biological Drugs Market Size by Type
2.3.1 Biosimilars and Innovative Biological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
2.4 Biosimilars and Innovative Biological Drugs Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Biosimilars and Innovative Biological Drugs Market Size by Application
2.5.1 Biosimilars and Innovative Biological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
3 BIOSIMILARS AND INNOVATIVE BIOLOGICAL DRUGS MARKET SIZE BY PLAYER
3.1 Biosimilars and Innovative Biological Drugs Market Size Market Share by Player
3.1.1 Global Biosimilars and Innovative Biological Drugs Revenue by Player (2019-2024)
3.1.2 Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Biosimilars and Innovative Biological Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOSIMILARS AND INNOVATIVE BIOLOGICAL DRUGS BY REGION
4.1 Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024)
4.2 Global Biosimilars and Innovative Biological Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
4.4 APAC Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
4.5 Europe Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024)
5.2 Americas Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
5.3 Americas Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024)
6.2 APAC Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
6.3 APAC Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024)
7.2 Europe Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
7.3 Europe Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars and Innovative Biological Drugs by Region (2019-2024)
8.2 Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOSIMILARS AND INNOVATIVE BIOLOGICAL DRUGS MARKET FORECAST
10.1 Global Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.1.1 Global Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.1.2 Americas Biosimilars and Innovative Biological Drugs Forecast
10.1.3 APAC Biosimilars and Innovative Biological Drugs Forecast
10.1.4 Europe Biosimilars and Innovative Biological Drugs Forecast
10.1.5 Middle East & Africa Biosimilars and Innovative Biological Drugs Forecast
10.2 Americas Biosimilars and Innovative Biological Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Biosimilars and Innovative Biological Drugs Forecast
10.2.2 Canada Market Biosimilars and Innovative Biological Drugs Forecast
10.2.3 Mexico Market Biosimilars and Innovative Biological Drugs Forecast
10.2.4 Brazil Market Biosimilars and Innovative Biological Drugs Forecast
10.3 APAC Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.3.1 China Biosimilars and Innovative Biological Drugs Market Forecast
10.3.2 Japan Market Biosimilars and Innovative Biological Drugs Forecast
10.3.3 Korea Market Biosimilars and Innovative Biological Drugs Forecast
10.3.4 Southeast Asia Market Biosimilars and Innovative Biological Drugs Forecast
10.3.5 India Market Biosimilars and Innovative Biological Drugs Forecast
10.3.6 Australia Market Biosimilars and Innovative Biological Drugs Forecast
10.4 Europe Biosimilars and Innovative Biological Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Biosimilars and Innovative Biological Drugs Forecast
10.4.2 France Market Biosimilars and Innovative Biological Drugs Forecast
10.4.3 UK Market Biosimilars and Innovative Biological Drugs Forecast
10.4.4 Italy Market Biosimilars and Innovative Biological Drugs Forecast
10.4.5 Russia Market Biosimilars and Innovative Biological Drugs Forecast
10.5 Middle East & Africa Biosimilars and Innovative Biological Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Biosimilars and Innovative Biological Drugs Forecast
10.5.2 South Africa Market Biosimilars and Innovative Biological Drugs Forecast
10.5.3 Israel Market Biosimilars and Innovative Biological Drugs Forecast
10.5.4 Turkey Market Biosimilars and Innovative Biological Drugs Forecast
10.6 Global Biosimilars and Innovative Biological Drugs Forecast by Type (2025-2030)
10.7 Global Biosimilars and Innovative Biological Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biosimilars and Innovative Biological Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Biosimilars and Innovative Biological Drugs Product Offered
11.1.3 Roche Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Biosimilars and Innovative Biological Drugs Product Offered
11.2.3 Amgen Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Biosimilars and Innovative Biological Drugs Product Offered
11.3.3 AbbVie Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Biosimilars and Innovative Biological Drugs Product Offered
11.4.3 Sanofi Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Biosimilars and Innovative Biological Drugs Product Offered
11.5.3 Johnson & Johnson Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Biosimilars and Innovative Biological Drugs Product Offered
11.6.3 Pfizer Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Biosimilars and Innovative Biological Drugs Product Offered
11.7.3 Novo Nordisk Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novo Nordisk Main Business Overview
11.7.5 Novo Nordisk Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Biosimilars and Innovative Biological Drugs Product Offered
11.8.3 Eli Lilly Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Biosimilars and Innovative Biological Drugs Product Offered
11.9.3 Novartis Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Biosimilars and Innovative Biological Drugs Product Offered
11.10.3 Merck Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Biogen
11.11.1 Biogen Company Information
11.11.2 Biogen Biosimilars and Innovative Biological Drugs Product Offered
11.11.3 Biogen Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biogen Main Business Overview
11.11.5 Biogen Latest Developments
11.12 Celltrion
11.12.1 Celltrion Company Information
11.12.2 Celltrion Biosimilars and Innovative Biological Drugs Product Offered
11.12.3 Celltrion Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Celltrion Main Business Overview
11.12.5 Celltrion Latest Developments
11.13 Sobi
11.13.1 Sobi Company Information
11.13.2 Sobi Biosimilars and Innovative Biological Drugs Product Offered
11.13.3 Sobi Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Sobi Main Business Overview
11.13.5 Sobi Latest Developments
11.14 3SBIO
11.14.1 3SBIO Company Information
11.14.2 3SBIO Biosimilars and Innovative Biological Drugs Product Offered
11.14.3 3SBIO Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 3SBIO Main Business Overview
11.14.5 3SBIO Latest Developments
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Information
11.15.2 Changchun High Tech Biosimilars and Innovative Biological Drugs Product Offered
11.15.3 Changchun High Tech Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Changchun High Tech Main Business Overview
11.15.5 Changchun High Tech Latest Developments
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Information
11.16.2 Kanghong Pharma Biosimilars and Innovative Biological Drugs Product Offered
11.16.3 Kanghong Pharma Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Kanghong Pharma Main Business Overview
11.16.5 Kanghong Pharma Latest Developments
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Information
11.17.2 Innovent Biologics Biosimilars and Innovative Biological Drugs Product Offered
11.17.3 Innovent Biologics Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Innovent Biologics Main Business Overview
11.17.5 Innovent Biologics Latest Developments
11.18 Gan&Lee
11.18.1 Gan&Lee Company Information
11.18.2 Gan&Lee Biosimilars and Innovative Biological Drugs Product Offered
11.18.3 Gan&Lee Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Gan&Lee Main Business Overview
11.18.5 Gan&Lee Latest Developments
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Information
11.19.2 Tonghua Dongbao Biosimilars and Innovative Biological Drugs Product Offered
11.19.3 Tonghua Dongbao Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Tonghua Dongbao Main Business Overview
11.19.5 Tonghua Dongbao Latest Developments
11.20 United Laboratory
11.20.1 United Laboratory Company Information
11.20.2 United Laboratory Biosimilars and Innovative Biological Drugs Product Offered
11.20.3 United Laboratory Biosimilars and Innovative Biological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 United Laboratory Main Business Overview
11.20.5 United Laboratory Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biosimilars and Innovative Biological Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Biosimilars and Innovative Biological Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Interferon
Table 5. Major Players of Insulin
Table 6. Major Players of Vaccines
Table 7. Major Players of Others
Table 8. Biosimilars and Innovative Biological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Table 11. Biosimilars and Innovative Biological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Table 14. Global Biosimilars and Innovative Biological Drugs Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Player (2019-2024)
Table 16. Biosimilars and Innovative Biological Drugs Key Players Head office and Products Offered
Table 17. Biosimilars and Innovative Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Table 22. Global Biosimilars and Innovative Biological Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Biosimilars and Innovative Biological Drugs Market Size Market Share by Country (2019-2024)
Table 26. Americas Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Table 28. Americas Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Table 30. APAC Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Table 32. APAC Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Country (2019-2024)
Table 36. Europe Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Biosimilars and Innovative Biological Drugs
Table 42. Key Market Challenges & Risks of Biosimilars and Innovative Biological Drugs
Table 43. Key Industry Trends of Biosimilars and Innovative Biological Drugs
Table 44. Global Biosimilars and Innovative Biological Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Biosimilars and Innovative Biological Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Biosimilars and Innovative Biological Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Biosimilars and Innovative Biological Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Roche Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 49. Roche Biosimilars and Innovative Biological Drugs Product Offered
Table 50. Roche Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Roche Main Business
Table 52. Roche Latest Developments
Table 53. Amgen Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 54. Amgen Biosimilars and Innovative Biological Drugs Product Offered
Table 55. Amgen Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Amgen Main Business
Table 57. Amgen Latest Developments
Table 58. AbbVie Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 59. AbbVie Biosimilars and Innovative Biological Drugs Product Offered
Table 60. AbbVie Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. AbbVie Main Business
Table 62. AbbVie Latest Developments
Table 63. Sanofi Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 64. Sanofi Biosimilars and Innovative Biological Drugs Product Offered
Table 65. Sanofi Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments
Table 68. Johnson & Johnson Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 69. Johnson & Johnson Biosimilars and Innovative Biological Drugs Product Offered
Table 70. Johnson & Johnson Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Johnson & Johnson Main Business
Table 72. Johnson & Johnson Latest Developments
Table 73. Pfizer Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 74. Pfizer Biosimilars and Innovative Biological Drugs Product Offered
Table 75. Pfizer Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Novo Nordisk Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 79. Novo Nordisk Biosimilars and Innovative Biological Drugs Product Offered
Table 80. Novo Nordisk Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Eli Lilly Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 84. Eli Lilly Biosimilars and Innovative Biological Drugs Product Offered
Table 85. Eli Lilly Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Novartis Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 89. Novartis Biosimilars and Innovative Biological Drugs Product Offered
Table 90. Novartis Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Merck Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 94. Merck Biosimilars and Innovative Biological Drugs Product Offered
Table 95. Merck Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Biogen Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 99. Biogen Biosimilars and Innovative Biological Drugs Product Offered
Table 100. Biogen Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Biogen Main Business
Table 102. Biogen Latest Developments
Table 103. Celltrion Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 104. Celltrion Biosimilars and Innovative Biological Drugs Product Offered
Table 105. Celltrion Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Celltrion Main Business
Table 107. Celltrion Latest Developments
Table 108. Sobi Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 109. Sobi Biosimilars and Innovative Biological Drugs Product Offered
Table 110. Sobi Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Sobi Main Business
Table 112. Sobi Latest Developments
Table 113. 3SBIO Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 114. 3SBIO Biosimilars and Innovative Biological Drugs Product Offered
Table 115. 3SBIO Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. 3SBIO Main Business
Table 117. 3SBIO Latest Developments
Table 118. Changchun High Tech Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 119. Changchun High Tech Biosimilars and Innovative Biological Drugs Product Offered
Table 120. Changchun High Tech Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Changchun High Tech Main Business
Table 122. Changchun High Tech Latest Developments
Table 123. Kanghong Pharma Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 124. Kanghong Pharma Biosimilars and Innovative Biological Drugs Product Offered
Table 125. Kanghong Pharma Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Kanghong Pharma Main Business
Table 127. Kanghong Pharma Latest Developments
Table 128. Innovent Biologics Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 129. Innovent Biologics Biosimilars and Innovative Biological Drugs Product Offered
Table 130. Innovent Biologics Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Innovent Biologics Main Business
Table 132. Innovent Biologics Latest Developments
Table 133. Gan&Lee Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 134. Gan&Lee Biosimilars and Innovative Biological Drugs Product Offered
Table 135. Gan&Lee Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Gan&Lee Main Business
Table 137. Gan&Lee Latest Developments
Table 138. Tonghua Dongbao Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 139. Tonghua Dongbao Biosimilars and Innovative Biological Drugs Product Offered
Table 140. Tonghua Dongbao Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Tonghua Dongbao Main Business
Table 142. Tonghua Dongbao Latest Developments
Table 143. United Laboratory Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 144. United Laboratory Biosimilars and Innovative Biological Drugs Product Offered
Table 145. United Laboratory Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. United Laboratory Main Business
Table 147. United Laboratory Latest Developments
Table 1. Biosimilars and Innovative Biological Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Biosimilars and Innovative Biological Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Interferon
Table 5. Major Players of Insulin
Table 6. Major Players of Vaccines
Table 7. Major Players of Others
Table 8. Biosimilars and Innovative Biological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Table 11. Biosimilars and Innovative Biological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Table 14. Global Biosimilars and Innovative Biological Drugs Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Player (2019-2024)
Table 16. Biosimilars and Innovative Biological Drugs Key Players Head office and Products Offered
Table 17. Biosimilars and Innovative Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Table 22. Global Biosimilars and Innovative Biological Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Biosimilars and Innovative Biological Drugs Market Size Market Share by Country (2019-2024)
Table 26. Americas Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Table 28. Americas Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Table 30. APAC Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Table 32. APAC Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Biosimilars and Innovative Biological Drugs Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Country (2019-2024)
Table 36. Europe Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Biosimilars and Innovative Biological Drugs
Table 42. Key Market Challenges & Risks of Biosimilars and Innovative Biological Drugs
Table 43. Key Industry Trends of Biosimilars and Innovative Biological Drugs
Table 44. Global Biosimilars and Innovative Biological Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Biosimilars and Innovative Biological Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Biosimilars and Innovative Biological Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Biosimilars and Innovative Biological Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Roche Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 49. Roche Biosimilars and Innovative Biological Drugs Product Offered
Table 50. Roche Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Roche Main Business
Table 52. Roche Latest Developments
Table 53. Amgen Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 54. Amgen Biosimilars and Innovative Biological Drugs Product Offered
Table 55. Amgen Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Amgen Main Business
Table 57. Amgen Latest Developments
Table 58. AbbVie Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 59. AbbVie Biosimilars and Innovative Biological Drugs Product Offered
Table 60. AbbVie Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. AbbVie Main Business
Table 62. AbbVie Latest Developments
Table 63. Sanofi Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 64. Sanofi Biosimilars and Innovative Biological Drugs Product Offered
Table 65. Sanofi Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments
Table 68. Johnson & Johnson Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 69. Johnson & Johnson Biosimilars and Innovative Biological Drugs Product Offered
Table 70. Johnson & Johnson Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Johnson & Johnson Main Business
Table 72. Johnson & Johnson Latest Developments
Table 73. Pfizer Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 74. Pfizer Biosimilars and Innovative Biological Drugs Product Offered
Table 75. Pfizer Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Novo Nordisk Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 79. Novo Nordisk Biosimilars and Innovative Biological Drugs Product Offered
Table 80. Novo Nordisk Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Eli Lilly Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 84. Eli Lilly Biosimilars and Innovative Biological Drugs Product Offered
Table 85. Eli Lilly Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Novartis Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 89. Novartis Biosimilars and Innovative Biological Drugs Product Offered
Table 90. Novartis Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Merck Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 94. Merck Biosimilars and Innovative Biological Drugs Product Offered
Table 95. Merck Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Biogen Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 99. Biogen Biosimilars and Innovative Biological Drugs Product Offered
Table 100. Biogen Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Biogen Main Business
Table 102. Biogen Latest Developments
Table 103. Celltrion Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 104. Celltrion Biosimilars and Innovative Biological Drugs Product Offered
Table 105. Celltrion Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Celltrion Main Business
Table 107. Celltrion Latest Developments
Table 108. Sobi Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 109. Sobi Biosimilars and Innovative Biological Drugs Product Offered
Table 110. Sobi Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Sobi Main Business
Table 112. Sobi Latest Developments
Table 113. 3SBIO Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 114. 3SBIO Biosimilars and Innovative Biological Drugs Product Offered
Table 115. 3SBIO Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. 3SBIO Main Business
Table 117. 3SBIO Latest Developments
Table 118. Changchun High Tech Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 119. Changchun High Tech Biosimilars and Innovative Biological Drugs Product Offered
Table 120. Changchun High Tech Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Changchun High Tech Main Business
Table 122. Changchun High Tech Latest Developments
Table 123. Kanghong Pharma Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 124. Kanghong Pharma Biosimilars and Innovative Biological Drugs Product Offered
Table 125. Kanghong Pharma Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Kanghong Pharma Main Business
Table 127. Kanghong Pharma Latest Developments
Table 128. Innovent Biologics Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 129. Innovent Biologics Biosimilars and Innovative Biological Drugs Product Offered
Table 130. Innovent Biologics Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Innovent Biologics Main Business
Table 132. Innovent Biologics Latest Developments
Table 133. Gan&Lee Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 134. Gan&Lee Biosimilars and Innovative Biological Drugs Product Offered
Table 135. Gan&Lee Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Gan&Lee Main Business
Table 137. Gan&Lee Latest Developments
Table 138. Tonghua Dongbao Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 139. Tonghua Dongbao Biosimilars and Innovative Biological Drugs Product Offered
Table 140. Tonghua Dongbao Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Tonghua Dongbao Main Business
Table 142. Tonghua Dongbao Latest Developments
Table 143. United Laboratory Details, Company Type, Biosimilars and Innovative Biological Drugs Area Served and Its Competitors
Table 144. United Laboratory Biosimilars and Innovative Biological Drugs Product Offered
Table 145. United Laboratory Biosimilars and Innovative Biological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. United Laboratory Main Business
Table 147. United Laboratory Latest Developments
LIST OF FIGURES
Figure 1. Biosimilars and Innovative Biological Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilars and Innovative Biological Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Biosimilars and Innovative Biological Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biosimilars and Innovative Biological Drugs Sales Market Share by Country/Region (2023)
Figure 8. Biosimilars and Innovative Biological Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Type in 2023
Figure 10. Biosimilars and Innovative Biological Drugs in Hospital
Figure 11. Global Biosimilars and Innovative Biological Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. Biosimilars and Innovative Biological Drugs in Retail Pharmacy
Figure 13. Global Biosimilars and Innovative Biological Drugs Market: Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Biosimilars and Innovative Biological Drugs in Other
Figure 15. Global Biosimilars and Innovative Biological Drugs Market: Other (2019-2024) & ($ millions)
Figure 16. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Application in 2023
Figure 17. Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Player in 2023
Figure 18. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas Biosimilars and Innovative Biological Drugs Value Market Share by Country in 2023
Figure 24. United States Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 61. China Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 65. India Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 68. France Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global Biosimilars and Innovative Biological Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Biosimilars and Innovative Biological Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biosimilars and Innovative Biological Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilars and Innovative Biological Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Biosimilars and Innovative Biological Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biosimilars and Innovative Biological Drugs Sales Market Share by Country/Region (2023)
Figure 8. Biosimilars and Innovative Biological Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Type in 2023
Figure 10. Biosimilars and Innovative Biological Drugs in Hospital
Figure 11. Global Biosimilars and Innovative Biological Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. Biosimilars and Innovative Biological Drugs in Retail Pharmacy
Figure 13. Global Biosimilars and Innovative Biological Drugs Market: Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Biosimilars and Innovative Biological Drugs in Other
Figure 15. Global Biosimilars and Innovative Biological Drugs Market: Other (2019-2024) & ($ millions)
Figure 16. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Application in 2023
Figure 17. Global Biosimilars and Innovative Biological Drugs Revenue Market Share by Player in 2023
Figure 18. Global Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas Biosimilars and Innovative Biological Drugs Value Market Share by Country in 2023
Figure 24. United States Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Biosimilars and Innovative Biological Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 61. China Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 65. India Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 68. France Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Biosimilars and Innovative Biological Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global Biosimilars and Innovative Biological Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Biosimilars and Innovative Biological Drugs Market Size Market Share Forecast by Application (2025-2030)
